OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-04-05-accounts

Trustees’ Annual Report for the period

From 06/04/2024 Period start date To 05/04/2025 Period end date

Charity name: Insulinoma Charity UK

Charity registration number: 1204926

Objectives and Activities

SORP reference
Summary of the purposes of
the charity as set out in its
governing document
Para 1.17 Insulinoma Charity UK exists to relieve sickness
and preserve health by supporting people
affected by insulinoma and related
neuroendocrine tumours. The charity aims to
raise awareness of insulinoma, improve
understanding of the condition among
patients, families, and professionals, and
provide information, advocacy, and support to
those impacted. The charity also seeks to
promote education and public awareness of
rare endocrine conditions to improve
diagnosis, care, and outcomes.
Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.
Para 1.17 and
1.19
During the period, the charity focused on
awareness raising, patient support, and
information sharing. Activities included
providing guidance and signposting to
individuals affected by insulinoma, sharing
lived experience stories to improve public and
professional understanding, and supporting
families navigating complex diagnostic and
treatment pathways. The charity also engaged
with patients and carers to reduce isolation
and ensure that accurate, accessible
information about insulinoma was available to
those who need it.
Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit
Para 1.18 The trustees have had due regard to the
Charity Commission’s guidance on public
benefit. The activities undertaken during the
period were carried out to benefit people
affected by insulinoma and the wider public by
increasing awareness of a rare condition,
supporting informed decision making, and
promoting earlier recognition and
understandingof symptoms.

Additional information (optional)

You may choose to include further statements where relevant about:

SORP reference
Policy on grant making Para 1.38 The charity does not operate a grant making
programme and does not make personal
financial grants to individuals. Any payments
made are strictly for services provided, such as
the preparation and sharing of lived experience
material and are documented and
proportionate.
Policy on social investment
including program related
investment
Para 1.38 The charity has not undertaken any social
investments during the period.
Contribution made by
volunteers
Para 1.38 The charity relies significantly on voluntary
input. Trustees and volunteers contribute time,
expertise, and lived experience to support
beneficiaries, develop resources, and raise
awareness of insulinoma.
Other

Achievements and Performance

SORP reference
Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.
Para 1.20 During the period, Insulinoma Charity UK
established a clear presence as a support and
awareness organisation for people affected by
insulinoma. The charity supported individuals
and families during diagnosis and treatment,
shared personal stories to raise awareness of
rare disease impact, and helped reduce
isolation for those affected. The work
undertaken contributed to greater
understanding of insulinoma and highlighted
the real-world challenges faced by patients and
carers.

Additional information (optional) You may choose to include further statements where relevant about:

Achievements against
objectives set
Achievements against
objectives set
Para 1.41 The charity successfully delivered its core
objectives of awareness raising and patient
support during the period, despite being at an
early stage of development.
Performance of fundraising
activities against objectives
set
Para 1.41 Fundraising activity during the period was
limited and primarily involved voluntary
donations via online platforms. No formal
fundraising campaigns were undertaken.
Investment performance
against objectives
Para 1.41 The charity did not undertake any investments
during the reporting period. Accordingly, there
is no investment performance to report against
objectives. The trustees’ approach during the
period was to hold funds as cash only, ensuring
liquidity and prudent financial management
while the charity remains at an early stage of
development. This approach was consistent
with the charity’s objectives and risk
managementpriorities.
Other

Financial Review

Financial Review
Review of the charity’s
financial position at the end
of the period
Para 1.21 At the end of the period, the charity’s financial
position consisted solely of unrestricted funds
held in cash. All funds were held either directly
by the charity or temporarily on its behalf by
the JustGiving platform. No payments, asset
purchases, or investments were made during
theperiod.
Statement explaining the
policy for holding reserves
stating why they are held
Para 1.22 The trustees have reviewed the charity’s
reserves policy. Given the early stage of the
charity and its current scale of activity, funds
are held to meet short term operational needs
and to ensure continuity of charitable
activities.
Amount of reserves held Para 1.22 £6,992
Reasons for holding zero
reserves
Para 1.22 N/A
Details of fund materially in
deficit
Para 1.24 None
Explanation of any
uncertainties about the
charity continuing as a going
concern
Para 1.23 The trustees consider Insulinoma Charity UK to
be a going concern and believe it has adequate
resources to continue its activities for the
foreseeable future.

Additional information (optional) You may choose to include further statements where relevant about:

The charity’s principal
sources of funds (including
any fundraising)
Para 1.47 The charity’s principal source of funds during
the period was voluntary donations received
via online fundraising platforms.
Investment policy and
objectives including any
social investment policy
adopted
Para 1.46 The charity does not currently operate an
investment policy. All funds are held as cash.
A description of the principal
risks facing the charity
Para 1.46 The trustees have identified the charity’s
principal risks as reliance on voluntary income,
limited resources, and trustee capacity. These
risks are mitigated through careful financial
oversight, prudent decision making, and
gradual, sustainable development of activities.
Other

Structure, Governance and Management

Description of charity’s
trusts:
Insulinoma Charity UK does not operate or
administer any trusts. The charity does not
hold funds on trust for specific beneficiaries or
purposes beyond its general charitable
objectives. All funds received are held and
applied in accordance with the charity’s
governing document and Charity Commission
regulations.
Type of governing document
(trust deed, royal charter)
Para 1.25 Insulinoma Charity UK is constituted as an
unincorporated association and is governed by
its constitution.
How is the charity
constituted?
(e.g unincorporated
association, CIO)
Para 1.25 Unincorporated association
Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees
Para 1.25 Appointed by founding trustee Enola Wright
Additional information (optional)
You may choose to include further statements
Additional information (optional)
You may choose to include further statements
where relevant about:
Policies and procedures
adopted for the induction
and training of trustees
Para 1.51 Trustees receive induction appropriate to their
role and are supported to understand their
legal duties and responsibilities under charity
law.
The charity’s organisational
structure and any wider
network with which the
charity works
Para 1.51 The charity is trustee led and operates without
paid staff. Trustees collectively manage
strategy, governance, and operations.
Relationship with any
related parties
Para 1.51 There are no undisclosed related party
transactions.
Other

Reference and Administrative details

Charity name Insulinoma Charity UK
Other name the charity uses None
Registered charity number 1204926
Charity’s principal address 96 Empress Ave
West Mersea
Colchester
CO5 8BL

Names of the charity trustees who manage the charity

1
2
3
Trustee name Office (if any) Dates acted if not for whole
**year **
Name of person (or body) entitled
to appoint trustee (ifany)
Enola Patricia Wright Founder Enola Patricia Wright
Peter David Collins Treasurer
Paula Anne Davies Secretary

– Corporate trustees names of the directors at the date the report was approved

Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name **Dates acted if not for whole year **
N/A

Funds held as custodian trustees on behalf of others

Description of the assets The charity did not hold any funds or other assets as custodian held in this capacity trustee on behalf of others during the reporting period. Name and objects of the Not applicable, as no assets were held on behalf of another charity on whose behalf the charity or third party. assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable. As no custodial assets were held, there were no safe custody and arrangements required for custody or segregation beyond the segregation of such assets charity’s standard financial controls for its own funds. from the charity’s own assets

Additional information (optional)

Names and addresses of advisers (Optional information)

Type of Name Address
adviser

Name of chief executive or names of senior staff members (Optional information)

Exemptions from disclosure

Reason for non-disclosure of key personnel details

The charity has not disclosed detailed information about key personnel in order to protect personal privacy and security. Given the small size of the charity and the limited number of individuals involved in its governance and operations, the trustees consider that disclosure of detailed personal information is not necessary for transparency and could place individuals at risk. This approach is consistent with Charity Commission guidance and data protection principles.

Other optional information

During the reporting period, the charity continued to operate at an early stage of development, focusing on establishing sound governance, compliance with Charity Commission requirements, and a clear framework for future activity. The trustees remained mindful of proportionality, ensuring that resources were used effectively and in line with the charity’s objects. The charity did not employ staff during the period and relied on trustee and volunteer input to deliver its activities.

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s)
Full name(s)
Position (eg Secretary,
Chair, etc)
Date
Enola Wright P Collins
Enola Patricia Wright Peter David Collins

Founder
Treasurer
12 January 2026
12 January 2026

Charity Name No (if any) Insulinoma Charity UK 1204926 Receipts and payments accounts CC16a For the period Period start date Period end date To from 06/04/2024 05/04/2025

Section A Receipts and payments

A1 Receipts Unrestricted
funds
to the nearest £
-
4
3,650
-
4,605
- 4,220
73

4,112
-
-
-
4,112
900
156
-
-
-
-
-
-
-
1,056
-
-
-
1,056
3,056
-
-
3,056
Restricted
funds
to the nearest £
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Endowment
funds
to the nearest £
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total funds
to the nearest £
-
-
4
3,650
-
4,605
- 4,220
73
4,112
-
-
-
4,112
900
156
-
-
-
-
-
-
-
1,056
-
-
-
1,056
3,056
Total funds
to the nearest £
-
-
4
3,650
-
4,605
- 4,220
73
4,112
-
-
-
4,112
900
156
-
-
-
-
-
-
-
1,056
-
-
-
1,056
3,056
Last year
to the nearest £
Initial donation - 250
Corporate donations 200
Insulinoma e-Bookproceeds 4 45
Private donations 3,650 1,150
Just Givingfunds - Enola Wright - 1,127
Just Givingfunds - Insulinoma CharityUK 4,605 4,220
Adjustment - Just Giving funds -
Insulinoma Charity UK - amount incorrectly
shown as receipt in A1 Receipts in 2024
and in B2 Other Monetary Asset in 2024 -
receipt was actually post Year End in 2024
- 4,220 -
Deposit Account Interest 73 -
Sub total(Gross income for
AR)

4,112
6,992
A2 Asset and investment sales,
(see table).
-
- -
Sub total - -
Total receipts
A3 Payments
6,992
Fund raisingevent costs/fees 900 -
Software and Website fees/licenses 156 -
- -
- -
- -
- -
- -
- -
- -
**Sub total ** 1,056 -
A4 Asset and investment
purchases, (see table)
-
-
**Sub total ** - -
Total payments
Net of receipts/(payments)
A5 Transfers between funds
A6 Cash funds last year end
Cash funds this year end
-
3,056 - 3,056 6,992
- - - -
- - - -
3,056 - 3,056 6,992

CCXX R1 accounts (SS)

12/01/2026

1

Section B Statement of assets and liabilities at the end of the period

Categories
Signed by one or two trustees on
behalf of all the trustees
B1 Cash funds
B2 Other monetary assets
B4 Assets retained for the
charity’s own use
B5 Liabilities
B3 Investment assets
Signature
Details
Details
Co-operative Bank - Current Account
Co-operative Bank - Deposit Account
Details
Details
Total cash funds
(agree balances with receipts and payments
account(s))
Details
Unrestricted
funds
Restricted
funds
to nearest £
to nearest £
725
-
9,323
-
-
-
10,048
-
Agreement Error
OK
Unrestricted
funds
Restricted
funds
to nearest £
to nearest £
-
-
-
-
-
-
-
-
-
-
-
-
Fund to which
asset belongs
Cost (optional)
-
-
-
-
-
Fund to which
asset belongs
Cost (optional)
-
-
-
-
-
-
-
-
-
Fund to which
liability relates
Amount due
(optional)
-
-
-
-
-
Print Name
Enola Wright
Peter Collins
Endowment
funds
to nearest £
-
-
-
-
OK
Endowment
funds
to nearest £
-
-
-
-
-
-
Current value
(optional)
-
-
-
-
-
Current value
(optional)
-
-
-
-
-
-
-
-
-
When due
(optional)
Date of
approval
Enola Wright 17/12/2025
Peter Collins 17/12/2025

CCXX R2 accounts (SS)

12/01/2026

2